Education Creates Inroads for Concurrent Pediatric Care

Why It Matters

Improving clinician knowledge and payment clarity will broaden access to concurrent pediatric hospice, lowering costs and enhancing quality of life for families facing terminal illness.

Key Takeaways

• Clinicians often unaware of concurrent hospice options for children
• Education improves referral pathways and sustainable payment models
• Concurrent care reduces aggressive treatments and end‑of‑life costs
• Medicaid/CHIP reimbursement enables hospice alongside curative therapies
• Misbilling and unclear coverage hinder program sustainability

Pulse Analysis

Concurrent pediatric hospice, authorized by the 2010 ACA, uniquely permits children to receive hospice support while still undergoing curative therapies such as chemotherapy or ventilation. This dual approach addresses the holistic needs of the child—physical, emotional, spiritual—and offers families a safety net that traditional adult hospice models lack. By integrating services like 24/7 nursing, respite care, and complementary therapies, the model not only improves patient comfort but also aligns with cost‑containment goals, as studies show reduced utilization of intensive interventions at the end of life.

Despite its promise, the model suffers from a pervasive knowledge gap among physicians, nurses, and social workers. Many providers mistakenly believe hospice enrollment requires abandoning curative treatment, leading to delayed referrals and missed opportunities for early support. Educational initiatives—such as conference sessions, webinars, and interdisciplinary training—are essential to demystify concurrent care eligibility and to illustrate its impact on caregiver burnout and anticipatory grief. When clinicians understand the full spectrum of services, they can more confidently guide families toward a coordinated care plan that balances hope with realistic outcomes.

Financial sustainability remains the final hurdle. While Medicaid and CHIP reimburse concurrent hospice services, billing complexities and ambiguous coverage definitions often result in under‑payment or costly misallocation of resources. Health systems must develop clear protocols and leverage tools that map reimbursable items—medication management, durable medical equipment, and therapy sessions—to appropriate codes. Policy makers can further support the model by issuing detailed guidance and simplifying claim processes. As reimbursement clarity improves, more hospices will adopt concurrent care, expanding access for vulnerable pediatric patients and delivering measurable savings for the health system.